In 2019 , Moderna spent some 33.3 million U.S. dollars on localized regenerative therapeutics as part of its research and development expenses . The statistic illustrates the research and development expenses of Moderna Inc. from 2017 to 2019 , by type . Moderna recently became widely known for being one of two companies worldwide which started clinical trials for a vaccine to fight the coronavirus disease 2019 ( COVID-19 ) .
